The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Speak Out Rheum: Fifty Years of APLAR

Speak Out Rheum: Fifty Years of APLAR

August 1, 2013 • By Prakash Pispati, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • Speak Out Rheum: The First Days of Rheumatology
  • Speak Out Rheum: ACR/EULAR Exchange Program Expands Rheumatology Networks
  • Speak Out Rheum: Under the Radar
Explore This Issue
August 2013
Also By This Author
  • Common Eponyms in Rheumatology
Fifty Years of APLAR
Attendees of the first conference of SEAPAL (now APLAR), held in 1968 in Mumbai (Bombay), India.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Asia Pacific League of Associations for Rheumatology (APLAR) covers nearly four billion people. As the sun rises over Japan and New Zealand and brightens our 27 member countries, including those in Central and West Asia, it’s time to celebrate our golden jubilee. The story began in 1961, when rheumatology was in its nascency. Two Australian physicians procured authority from the International League Against Rheumatism (ILAR) to initiate a regional professional society, the South East Asia and Pacific Area League (SEAPAL) akin to EULAR and PANLAR. SEAPAL was renamed as the Asian Pacific League Against Rheumatism in 1990.1

Drs. Ken Muirden (Australia), Richard Wigley (New Zealand), and John Darmawan (Indonesia) were prime movers in setting up rheumatology clinics in Indonesian villages. Their teams collated valuable data on patterns and prevalence of the burden of rheumatic diseases in these populations. Similarly, in my own humble way, I helped establish a network of free arthritis camps in impoverished Indian village settings. Each month I boarded a predawn train to travel to camp locations where I would examine and treat at least a hundred patients with the support of a team of young local doctors and paramedics. Over five years, 6,400 patients were examined and data about their diseases was processed in Mumbai in an era when laptops and mobile phones were fantasies. Interestingly, the findings suggested that the most common diagnosis was soft-tissue rheumatism (36%), followed by osteoarthritis (32%), rheumatoid arthritis (RA; 22%), gout (6%), lupus (4%), and juvenile inflammatory arthritis (2%).2 The antistreptolysin-O test (ASO) was frequently ordered, and since a slightly elevated result was considered to be specific for rheumatic fever, long-term penicillin injections may have been erroneously administered to thousands of children in the hope of preventing rheumatic heart disease. Whereas aspirin and nonsteroidal antiinflammatory drugs were used liberally, disease-modifying antirheumatic drugs (DMARDs) were used sparingly, if at all. Since packages of chloroquine tablets carried a picture of a mosquito, many doctors and patients thought it was irrational to prescribe antimalarials for RA. Methotrexate was feared as being a dangerous anticancer cytotoxic drug, which was rarely used. Thankfully, such apprehensions are rarely perceived today.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Educational Endeavors

Looking back, such humble endeavors helped establish rheumatology as a specialty in the Asian medical community. As APLAR president, I seized the golden opportunity to initiate and encourage rheumatology teaching through the creation of first-ever continuing medical education programs in Bangladesh, Sri Lanka, Pakistan, Myanmar, Muscat, and Dubai.

Pages: 1 2 | Single Page

Filed Under: Professional Topics Tagged With: APLAR, History, rheumatologyIssue: August 2013

You Might Also Like:
  • Speak Out Rheum: The First Days of Rheumatology
  • Speak Out Rheum: ACR/EULAR Exchange Program Expands Rheumatology Networks
  • Speak Out Rheum: Under the Radar
  • Speak Out Rheum: Are Independent Measures of Patient Satisfaction Reliable?

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.